{
    "organizations": [],
    "uuid": "881bbc5a96b85975683738aa30e007d129faeaca",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/04/26/globe-newswire-pacira-pharmaceuticals-announces-timing-for-first-quarter-2018-financial-results-webcast-and-conference-call.html",
    "ord_in_thread": 0,
    "title": "Pacira Pharmaceuticals Announces Timing for First Quarter 2018 Financial Results Webcast and Conference Call",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "PARSIPPANY, N.J., April 26, 2018 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that it will report its first quarter financial results before the open of the U.S. markets on Thursday, May 3, 2018. The announcement will be followed by a conference call at 8:30 a.m. ET. Participating in the call from Pacira will be Dave Stack, chairman and chief executive officer, and other members of the company’s senior management team.\nThe call can be accessed by dialing 1-877-845-0779 (domestic) or 1-720-545-0035 (international) ten minutes prior to the start of the call and providing the Conference ID 6585169. A replay of the call will be available approximately two hours after the completion of the call and can be accessed by dialing 1-855-859-2056 (domestic) or 1-404-537-3406 (international) and providing the Conference ID 6585169. The replay of the call will be available for one week from the date of the live call.\nThe live, listen-only webcast of the conference call can also be accessed by visiting the “Investors & Media” section of the company’s website at investor.pacira.com . A replay of the webcast will be archived on the Pacira website for two weeks following the call.\nAbout Pacira\nPacira Pharmaceuticals, Inc. (NASDAQ:PCRX) is a specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. The company’s flagship product, EXPAREL® (bupivacaine liposome injectable suspension), indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia, was commercially launched in the United States in April 2012. EXPAREL and two other products have successfully utilized DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. Additional information about Pacira is available at www.pacira.com .\nInvestor Contact: Pacira Pharmaceuticals, Inc. Christian Pedetti, (973) 254-4387 Christian.Pedetti@pacira.com\nSource:Pacira Pharmaceuticals, Inc.",
    "published": "2018-04-26T15:30:00.000+03:00",
    "crawled": "2018-04-26T18:34:39.025+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "parsippany",
        "april",
        "globe",
        "newswire",
        "pacira",
        "pharmaceutical",
        "nasdaq",
        "pcrx",
        "today",
        "announced",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "open",
        "market",
        "thursday",
        "may",
        "announcement",
        "followed",
        "conference",
        "call",
        "et",
        "participating",
        "call",
        "pacira",
        "dave",
        "stack",
        "chairman",
        "chief",
        "executive",
        "officer",
        "member",
        "company",
        "senior",
        "management",
        "team",
        "call",
        "accessed",
        "dialing",
        "domestic",
        "international",
        "ten",
        "minute",
        "prior",
        "start",
        "call",
        "providing",
        "conference",
        "id",
        "replay",
        "call",
        "available",
        "approximately",
        "two",
        "hour",
        "completion",
        "call",
        "accessed",
        "dialing",
        "domestic",
        "international",
        "providing",
        "conference",
        "id",
        "replay",
        "call",
        "available",
        "one",
        "week",
        "date",
        "live",
        "call",
        "live",
        "webcast",
        "conference",
        "call",
        "also",
        "accessed",
        "visiting",
        "investor",
        "medium",
        "section",
        "company",
        "website",
        "replay",
        "webcast",
        "archived",
        "pacira",
        "website",
        "two",
        "week",
        "following",
        "call",
        "pacira",
        "pacira",
        "pharmaceutical",
        "nasdaq",
        "pcrx",
        "specialty",
        "pharmaceutical",
        "company",
        "focused",
        "clinical",
        "commercial",
        "development",
        "new",
        "product",
        "meet",
        "need",
        "acute",
        "care",
        "practitioner",
        "patient",
        "company",
        "flagship",
        "product",
        "bupivacaine",
        "liposome",
        "injectable",
        "suspension",
        "indicated",
        "infiltration",
        "surgical",
        "site",
        "produce",
        "postsurgical",
        "analgesia",
        "commercially",
        "launched",
        "united",
        "state",
        "april",
        "exparel",
        "two",
        "product",
        "successfully",
        "utilized",
        "unique",
        "proprietary",
        "product",
        "delivery",
        "technology",
        "encapsulates",
        "drug",
        "without",
        "altering",
        "molecular",
        "structure",
        "release",
        "desired",
        "period",
        "time",
        "additional",
        "information",
        "pacira",
        "available",
        "investor",
        "contact",
        "pacira",
        "pharmaceutical",
        "christian",
        "pedetti",
        "source",
        "pacira",
        "pharmaceutical",
        "inc"
    ]
}